Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation

Clinical Transplantation

Volumn 22, Issue 5, 2008, Pages 617-623

  Sigdel, Tara K ^a   Lau, Ken ^a   Schilling, James ^a   Sarwal, Minnie ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Renal transplantation; Urinary proteomics

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA1 GLYCOPROTEIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AMYLASE; ANGIOTENSINOGEN; ANTITHROMBIN; ANTITHROMBIN III; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; CREATININE; CYSTATIN C; HAPTOGLOBIN; HEMOPEXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KERATIN; ORGANIC SOLVENT; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMA PROTEIN; PREALBUMIN; RETINOL BINDING PROTEIN; TRANSFERRIN; VITAMIN D BINDING PROTEIN;

ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; CENTRIFUGATION; CHILD; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FINANCIAL MANAGEMENT; FOCAL GLOMERULOSCLEROSIS; FREEZE DRYING; GEL ELECTROPHORESIS; GRAFT RECIPIENT; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRECIPITATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEINURIA; PROTEOMICS; URINALYSIS; VOLUNTEER;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMISTRY, ANALYTICAL; CHILD; CHILD, PRESCHOOL; FREEZE DRYING; HUMANS; KIDNEY TRANSPLANTATION; PRIMARY GRAFT DYSFUNCTION; PROTEINS; PROTEOMICS; URINALYSIS;

EID: 52649094889     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00833.x     Document Type: Article

References (22)

1. Roelofsen H, Alvarez-Liamas G, Schepers M et al. Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry. Proteome Sci 2007: 5: 2.
2. Gonzalez-Buitrago JM, Ferreira L, Lorenzo I. Urinary proteomics. Clin Chim Acta 2007: 375: 49.
3. Khan A, Packer NH. Simple urinary sample preparation for proteomic analysis. J Proteome Res 2006: 5: 2824.
4. Thongboonkerd V, Chutipongtanate S, Kanlaya R. Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J Proteome Res 2006: 5: 183.
5. Lafitte D, Dussol B, Andersen S et al. Optimized preparation of urine samples for two-dimensional electrophoresis and initial application to patient samples. Clin Biochem 2002: 35: 581.
6. Marshall T, Williams K. Two-dimensional electrophoresis of human urinary proteins following concentration by dye precipitation. Electrophoresis, 1996: 17: 1265.
7. Ettorre A, Rosli C, Silacci M et al. Recombinant antibodies for the depletion of abundant proteins from human serum. Proteomics 2006: 6: 4496.
8. Fountoulakis M, Juranville JF, Jiang L et al. Depletion of the high-abundance plasma proteins. Amino Acids 2004: 27: 249.
9. Liu T, Qian WJ, Gritsenko MA et al. Human plasma N -glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res 2005: 4: 2070.
10. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
11. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 1997: 18: 2071.
12. Sigdel TK, Cilliers R, Gursahaney PR et al. Fractionation of soluble proteins in Escherichia coli using DEAE-, SP-, and phenyl sepharose chromatographies. J Biomol Tech 2004: 15: 199.
13. Gorg A, Obermaier C, Boguth G et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000: 21: 1037.
14. Granger J, Siddigui J, Copeland S et al. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 2005: 5: 4713.
15. Zhou M, Lucas DA, Chan KC et al. An investigation into the human serum "interactome." Electrophoresis 2004: 25: 1289.
16. Pang JX, Giannini N, Dongre AR et al. Biomarker discovery in urine by proteomics. J Proteome Res 2002: 1: 161.
17. Park MR, Wang EH, Jin DC et al. Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics 2006: 6: 1066.
18. Oh J, Pyo JH, Jo EH et al. Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 2004: 4: 3485.
19. Schaub S, Wilkins JA, Antonovici M et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 2005: 5 (Pt. 1): 729.
20. Risch L, Blumberg A, Huber AR. Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates. Ren Fail 2001: 23: 439.
21. Lederer SR, Friedrich N, Regenbogen C et al. Non-invasive monitoring of renal transplant recipients: Urinary excretion of soluble adhesion molecules and of the complement-split product C4d. Nephron Clin Pract, 2003: 94: c19.
22. Tonshoff B, Blum WF, Vickers M et al. Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone. Eur J Endocrinol 1995: 132: 433.